Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
JOINN Laboratories (China) Co., Ltd. Class H ( (HK:6127) ) has issued an update.
JOINN Laboratories (China) Co., Ltd. has announced proposed amendments to its Articles of Association and the rules of procedures for its general meeting of shareholders. These changes are in response to the upcoming amendments to the Company Law of the People’s Republic of China, effective from July 1, 2024. The key amendments include altering the number of directors on the board and removing the supervisory committee, aligning with legal and regulatory updates. These changes are expected to impact the company’s governance structure and could influence its operational efficiency and compliance with new legal standards.
The most recent analyst rating on (HK:6127) stock is a Hold with a HK$16.30 price target. To see the full list of analyst forecasts on JOINN Laboratories (China) Co., Ltd. Class H stock, see the HK:6127 Stock Forecast page.
More about JOINN Laboratories (China) Co., Ltd. Class H
JOINN Laboratories (China) Co., Ltd. is a joint stock company incorporated in the People’s Republic of China. The company operates in the biotechnology and pharmaceutical industry, focusing on providing laboratory services and research support for drug development and testing.
Average Trading Volume: 6,769,040
Technical Sentiment Signal: Buy
Current Market Cap: HK$26.27B
For an in-depth examination of 6127 stock, go to TipRanks’ Overview page.